Business
Agreement to supply CBD to Cellulac plc
Agreement to supply CBD to Cellulac plc.
About this update from Chill Brands Group Plc
[{"type":"text","content":"\n \nRNS Number : 6525H Highlands Natural Resources PLC 02 August 2019 \n\nTHE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) NO. 596/2014. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.\n \n \n2 August 2019\n \nHighlands Natural Resources plc\n(\"Highlands\" or the \"Company\")\n \nAgreement to supply hemp-derived CBD to Cellulac plc\n \nHighlands, the London listed natural resources company, is pleased to announce that it has entered into a two-year agreement to provide hemp-derived cannabidiol (\"CBD\"), grown under quality-controlled conditions, with less than 0.2% Tetrahydrocannabinol (\"THC\"), to Cellulac plc (9.35% owned by Integumen plc) for conversion to medical grade CBD.\n \nThe agreement with Cellulac will provide for the conversion of the CBD, supplied by Highlands, into medical-grade CBD and submission of the finished products to Integumen's Labskin test facilities. The CBD will be infused on their Wound pHase and STOER range of wound care and skin care products, providing a vertically integrated farm-to-finished product to meet with the requirements of all parties to the agreement.\n \nThe establishment of Zoetic, Highland's wholly owned vertically integrated CBD operation in Colorado, has already seen a successful launch of premium CBD consumer products in a matter of months. In addition, Highlands has also identified higher value opportunities in the supply of quality controlled, hemp-derived CBD, for inclusion in medical devices, cosmeceutical and pharmaceutical products. \n \nRobert Price - Executive Chairman and CEO Highlands, comments:\n \n\"With over 110 varieties of hemp, there is a requirement to provide quality hemp-derived CBD to meet specifications for the medical, cosmeceutical and pharmaceutical sectors, grown under supervised quality-controlled conditions. \n \n\"Our state-of-the-art, 33,000-foot indoor hemp growing facility in Colorado, US, offers the quality and consistency grade needed to meet those requirements and we welcome the recognition of the quality products and the opportunity to collaborate with Cellulac and Integumen to deliver consumer products for wound ca...